Understanding OUR Cytokine-Based Immunotherapy Candidates Our Motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method selections remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/hex-trust-backed-by-morgan-creek-and-injective-in-warm-up-to-series-c-round/